Skip to main content
. 2017 Sep 19;2017(9):CD004198. doi: 10.1002/14651858.CD004198.pub3

Comparison 1.

Silboesterol versus placebo (stuttering priapism)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Reduction in frequency of priapism (after 2 weeks of 5 mg silboesterol) 1 Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
1.1 No attacks into the second week of treatment 1 Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]